• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS70205        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS61583        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS4221        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS60314        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:AP0152        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS1978        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS9913M        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS1258        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS6626        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:AP0060        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Targeting PI3K/Akt/Nrf2 pathway by glabridin alleviates acetaminophen-induced hepatic injury in rats
  Catalog No.:BS13278        Pubmed No.:33932887        PMCID:
  Details:
  Journal name:
• Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis
  Catalog No.:AP0060        Pubmed No.:31284007        PMCID:
  Details:
  Journal name:
• Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis
  Catalog No.:BS6007M        Pubmed No.:31284007        PMCID:
  Details:
  Journal name:
• Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis
  Catalog No.:BS13278        Pubmed No.:31284007        PMCID:
  Details:
  Journal name:
• Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis
  Catalog No.:BS12478        Pubmed No.:31284007        PMCID:
  Details:
  Journal name: